Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe
Blood Adv. 2025 Sep 24:bloodadvances.2025017081. doi: 10.1182/bloodadvances.2025017081.…
Optical Genome Mapping (OGM): Validation and Clinical Utility in the Cytogenetic Diagnosis of Multiple Myeloma
Am J Hematol. 2025 Sep 20. doi: 10.1002/ajh.70077. Online ahead…
Fixed-Duration Epcoritamab Plus R2 Drives Favorable Outcomes in Relapsed or Refractory Follicular Lymphoma
Blood. 2025 Sep 8:blood.2025029909. doi: 10.1182/blood.2025029909.…
Autologous stem cell transplantation in NK/T-cell lymphoma: Prognostic impact of EBV-DNA in a multinational cohort-A study by the EBMT Lymphoma Working Party
Hemasphere. 2025 Aug 15;9(8):e70184. doi: 10.1002/hem3.70184.…
Frailty dynamics and their impact on QoL in patients undergoing autologous HCT for multiple myeloma: Results from a multicentre GETH-TC study
Br J Haematol. 2025 Aug 12. doi: 10.1111/bjh.70068. Online ahead…
CD19 CAR T-Cell Therapy for Primary Mediastinal Large B-Cell Lymphoma: A CIBMTR Analysis
Am J Hematol. 2025 Aug 11. doi: 10.1002/ajh.70033. Online ahead…
Advancing the Integration of ‘Basic/Fundamental’ and Translational Cellular and Gene Therapy Science within the EBMT: Accelerating the Pathway to Progress
Bone Marrow Transplant. 2025 Aug 7. doi: 10.1038/s41409-025-02688-x.…
Outcomes of Allogeneic HCT in Hodgkin Lymphoma in the Era of Checkpoint Inhibitors: A Joint CIBMTR and EBMT Analysis
Blood. 2025 Jul 7:blood.2024027197. doi: 10.1182/blood.2024027197.…
Allogeneic haematopoietic cell transplantation in peripheral T-cell lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee
Lancet Haematol. 2025 Jul;12(7):e542-e554. doi: 10.1016/S2352-3026(25)00073-0.ABSTRACTAllogeneic…
Correction: Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation
Bone Marrow Transplant. 2025 Jun 30. doi: 10.1038/s41409-025-02664-5.…
Allogeneic haematopoietic cell transplant should still be considered as a curative option for relapsed/refractory large B-cell lymphoma, including in the CAR T-cell era
Br J Haematol. 2025 Jun 25. doi: 10.1111/bjh.20217. Online ahead…
Corrigendum to ‘Clinical Practice Recommendations for Hematopoietic Cell Transplantation.’ Transplant Cell Ther. 2024 Sep;30(9):832-843
Transplant Cell Ther. 2025 Jun 21:S2666-6367(25)01206-0. doi:…
